Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 5:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,280 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: Central Line Associated Blood Stream Infections (CLABSI)
Interventions: Infection Preventionist Led Best Practices Reminders; Behavioral
Lead sponsor: Swedish Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 17,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 19
States / cities: Anchorage, Alaska • Apple Valley, California • Burbank, California + 15 more

Conditions: HIV Infections, Sexually Transmitted Diseases, Pregnancy
Interventions: HIV, STD, and pregnancy prevention curriculum, Standard sexual education curriculum; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 11 Years to 16 Years
Enrollment: 3,007 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Circumcision, Male, HIV, AIDS
Interventions: Voluntary medical male circumcision; Procedure
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 539 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gonorrhea
Interventions: Listerine Antiseptic Mouthwash Product, Biotene Mouthwash; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cerebrospinal Fluid Leakage, Subdural
Interventions: Spinal Sealant, Standard of Care; Device · Other
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Bedford, Massachusetts

Conditions: Dengue Fever
Interventions: rDEN4delta30-200,201, Placebo; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pressure Ulcers
Interventions: DermaTherapy® Linen and underpads.; Device
Lead sponsor: Precision Fabrics Group, Inc.; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV Infections
Interventions: Attention-control group, MY-RIDE group; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 25 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Typhoid Fever
Interventions: Ty800 (Salmonella typhi) Oral Vaccine; Biological
Lead sponsor: Avant Immunotherapeutics; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 5
States / cities: San Diego, California • Melbourne, Florida • Peoria, Illinois + 2 more

Conditions: Recurrent UTIs, Catheter-Related Infections
Interventions: Nissle 1917; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: HIV, Substance Use Disorders, Substance Use, AIDS
Interventions: CC PrTNER; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 15 Years to 29 Years · Male only
Enrollment: 275 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland • Philadelphia, Pennsylvania

Conditions: Antibiotic Prophylaxis
Interventions: cefazolin or vancomycin, Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 251 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Herpes Labialis
Interventions: onabotulinumtoxinA, Bacteriostatic normal saline; Drug · Other
Lead sponsor: DeNova Research; Other
Eligibility: 18 Years to 64 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Adolescent Behavior, HIV/AIDS, PrEP
Interventions: Telehealth Coaching; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 15 Years to 21 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Influenza
Interventions: Influenzae vaccine; Drug
Lead sponsor: Akron Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 336 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Akron, Ohio

Conditions: PrEP, HIV Prevention Program
Interventions: Academic detailing; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Seropositivity, Pregnancy, High-Risk
Interventions: PrEP, Counseling on timed condomless sex, ART and PrEP adherence; Drug · Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 49 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Self Efficacy, HIV Prevention, STI Prevention
Interventions: Treat Act Know Engage (T.A.K.E.) Steps, Standard or Care; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 13 Years to 19 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 5
States / cities: Philadelphia, Pennsylvania

Conditions: Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents
Interventions: nasal antimicrobial photodisinfection therapy; Combination Product
Lead sponsor: Ondine Biomedical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 4,787 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 14
States / cities: Englewood, Colorado • Brandon, Florida • Largo, Florida + 9 more

Conditions: Urinary Tract Infections, Incontinence
Interventions: Cranberry extract capsules, Placebo capsule; Dietary Supplement
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cytomegalovirus Infection
Interventions: Letermovir, Placebo; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 10
States / cities: Duarte, California • Sacramento, California • Miami, Florida + 7 more

Conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
Interventions: moxifloxacin hydrochloride, Placebo; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 120 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Prevention of Zika Infection, Zika-Specific Immune Response
Interventions: VRC-ZKADNA085-00-VP; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 35 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Decatur, Georgia • Baltimore, Maryland • Bethesda, Maryland

Conditions: B-Acute Lymphoblastic Leukemia, CAR-T Cell Therapy, Cytokine Release Syndrome, Immune Effector Cell Associated Neurotoxicity Syndrome, Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome
Interventions: Anakinra (Kineret®); Drug
Lead sponsor: Kevin McNerney; Other
Eligibility: 1 Year to 25 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students

Male Circumcision Services for HIV Prevention in the Dominican Republic

Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention

Study to Evaluate Safety & Effectiveness of Spinal Sealant

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults

Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting

Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children

The Collaborative Care PrTNER Study

Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy

Botulinum Toxin A for Herpes Labialis

Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep South

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP

Safer Conception Intervention for HIV-1 Serodiscordant Couples

TAKE Steps: Motivational Interviewing to Prevent STIs

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults

Pre-emptive Anakinra for Cytokine Event Reduction